Roche

Protected: Immunotherapy combination now PBS listed for first-line treatment of metastatic non-squamous non-small cell lung cancer (1,2)

By ONA Editor October 1, 2019 No Comments

Prime Minister of Australia, The Hon. Scott Morrison MP with General Manager of Roche Australia, Stuart Knight

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

This post is password protected. Enter the password to view comments.

About Author

Related Posts

DNA methylation as a biomarker for early diagnosis of lung cancer

European Commission approves lazertinib in combination with amivantamab for the first-line treatment of patients with EGFR-mutated advanced NSCLC

Pharmacokinetics comparison of aumolertinib, osimertinib, gefitinib and their major metabolites in mouse model and NSCLC patients